
|Articles|July 1, 2002
Drug delivery devices useful for posterior segment diseases
Author(s)Julia Talsma
Durham, NC-Sustained-release drug delivery systems are a promising new approach for treating posterior segment diseases, according to Glenn J. Jaffe, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron receives another CRL for its Eylea 8 mg
2
UPDATE: STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
3
Topcon Healthcare seeks to advance company through acquisition and new investment
4
The future of glaucoma care: Where innovation meets everyday practice
5

















































.png)


